Merck (MRK -1.29%), a hefty dividend stock and one of the world's largest drugmakers, may seem like a stagnant big pharma to many investors -- but does the company still have room to grow? In this video, health care analyst Max Macaluso outlines some of the biggest opportunities that can drive Merck's growth in 2013 and beyond.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.